172165-56-9
172165-56-9
Chemical Structure
Acrivastine-d7
Synonym(s): BW825C d7
- CAS No.: 172165-56-9
- Formula:C22H17D7N2O2
- Molecular Weight:355.48
IUPAC Name: (E)-3-(6-((E)-1-(4-(methyl-d3)phenyl-2,3,5,6-d4)-3-(pyrrolidin-1-yl)prop-1-en-1-yl)pyridin-2-yl)acrylic acid
InChIKey: PWACSDKDOHSSQD-XQHWGIKSSA-N
SMILES: O=C(O)/C=C/C1=NC(/C(C2=C([2H])C([2H])=C(C([2H])([2H])[2H])C([2H])=C2[2H])=C/CN3CCCC3)=CC=C1
Biological Activity: Acrivastine-d7 is a deuterium labeled Acrivastine. Acrivastine is a short acting histamine 1 receptor antagonist.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Acrivastine-d7 | Acrivastine-d7 is a deuterium labeled Acrivastine. Acrivastine is a short acting histamine 1 receptor antagonist. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Acrivastine (Standard) | ≥98% | Acrivastine (Standard) is the analytical standard of Acrivastine. This product is intended for research and analytical applications. Acrivastine (BW825C) is a short acting histamine 1 receptor antagonist for the treatment of allergic rhinitis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Acrivastine | 99.86% | Acrivastine (BW825C) is a short acting histamine 1 receptor antagonist for the treatment of allergic rhinitis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
